Five questions for gynecologic oncologist Brittany Davidson, MD, about the best approach to patient goals and treatment expectations in terminal ovarian cancer
A study co-led at Duke SoM & Mass. General Hospital demonstrates benefits of early palliative care for high-risk leukemia patients. Results published in JAMA. Thomas LeBlanc, MD, is co-lead author.
When heart patients are referred to palliative care, they're typically nearing death and therefore benefit from hospice services geared to end-of-life.
The University of Colorado Anschutz Medical Campus received an $8 million, five-year continuation grant from the National Institute for Nursing Resear...
The DCI's Arif Kamal, MD, and Amy Abernethy, MD, are among the authors of the cover story of the May-June issue of Oncology Issues. Their article deta...
Arif Kamal, MD, MBA, MHS, associate professor of Medicine and Business Administration and physician director of Quality at the Duke Cancer Institute, ...
Leukemia patients who received frequent transfusions had short stays in hospice, suggesting that transfusion dependence presents a barrier to end-of-l...
Using a “mystery shopper” approach, researchers at Duke Cancer Institute anonymously called most of the nation’s comprehensive cancer centers to ask w...
Thomas LeBlanc, MD, a practicing hematologic oncologist and palliative care physician at Duke Cancer Institute, recently received the 2018 European As...
Thomas LeBlanc, MD, MA, MHS, was recently appointed a fellow of the American Academy of Hospice and Palliative Medicine (AAHPM). LeBlanc, a cell thera...
The Duke Cancer Center palliative care team. Pictured from left to right: Arif Kamal, M.D., director of quality outcomes with the Duke Cancer Institut...